Top compounds associated with response to TIGD7


Feature Type Standardized
Nominal ANOVA
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA Mitomycin-C GDSC1000 pan-cancer AAC -0.13 0.0007
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Gemcitabine gCSI pan-cancer AAC -0.18 0.001
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.12 0.001
mRNA embelin GDSC1000 pan-cancer AAC -0.12 0.001
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.1 0.002
Download CSV